产品库

RKI-1447,1342278-01-6

产品信息
  • 公告提醒:爱必信所有产品和服务仅用于科学研究不用于临床应用及其他用途提供产品和服务也不为任何个人提供产品和服务)!

     

    YZ剂描述:

    产品名称:RKI-1447

    产品别名:1-[(3-hydroxyphenyl)methyl]-3-(4-pyridin-4-yl-1,3-thiazol-2-yl)urea

    英文别名:RKI 1447;RKI1447

    靶点:ROCK2 ,ROCK1

    CAS:1342278-01-6

    纯度:>98%

    外观:Powder

    保存方法:store at -20℃ for one year(Powder); in DMSO or others solvent store at 2-4℃ for two weeks, at -80℃ for six months.

    描述:RKI-1447 is a potent small molecule inhibitor of ROCK1 and ROCK2.

    溶解性:DMSO65 mg/mL (199.16 mM)

    体外研究:

    RKI-1447 is a cell-permeable pyridylthiazolyl-urea that acts as a potent, ATP site-targeting Rho Kinase inhibitor, displaying much reduced potency against PKA, PKN1/PRK1, p70S6K/RPS6kB1, AKT1, MRCKa/CDC42BPA (85.5%, 80.5%, 61.9%, 56.0%, and 50.4% inhibition, respectively, by 1 µM RKI-1447) or 15 other kinases. Crystal structures of the RKI-1447/ROCK1 complex reveals that RKI-1447 is a Type I kinase inhibitor that binds the ATP binding site through interactions with the hinge region and the DFG motif. RKI-1447 suppresses phosphorylation of the ROCK substrates MLC-2 and MYPT-1 in human cancer cells, but had no effect on the phosphorylation levels of the AKT, MEK, and S6 kinase at concentrations as high as 10 μM. RKI-1447 is also highly selective at inhibiting ROCK-mediated cytoskeleton re-organization (actin stress fiber formation) following LPA stimulation, but does not affect PAK-meditated lamellipodia and filopodia formation following PDGF and Bradykinin stimulation. RKI-1447 inhibits migration, invasion and anchorage-independent tumor growth of breast cancer cells.

    体内研究:RKI-1447 is highly effective at inhibiting the outgrowth of mammary tumors in a transgenic mouse model. Tumors from mice treated with the RKI-1447 increases in size with an average percent change in tumor volume of only 8.8%. Thus, RKI-1447 inhibited mammary tumor growth by 87%, and on average the mammary tumors from Compared with those tumors from mice treated with the vehicle control, RKI-1447 treated mice are 7.7-fold smaller. RKI-1447 treatments does not result in mouse weight loss.

    产品信息订购:

      产品货号   产品名称   规格 价格 大包装及货期
      abs810410   RKI-1447   5mg  875   立即咨询

    产品更多信息请进入爱必信网站咨询

    温馨提示:不可用于临床ZL。
  • 信息声明:本产品供应信息由仪器网为您整合,供应商为(爱必信(上海)生物科技有限公司),内容包括 (RKI-1447,1342278-01-6)的品牌、型号、技术参数、详细介绍等;如果您想了解更多关于 (RKI-1447,1342278-01-6)的信息,请直接联系供应商,给供应商留言!
    供应商产品推荐
      您可能感兴趣的产品